Rupert J. Handgretinger
#132,125
Most Influential Person Now
Rupert J. Handgretinger's AcademicInfluence.com Rankings
Rupert J. Handgretingerbiology Degrees
Biology
#8794
World Rank
#11926
Historical Rank
Immunology
#509
World Rank
#526
Historical Rank
Download Badge
Biology
Rupert J. Handgretinger's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Immunology Stanford University
Similar Degrees You Can Earn
Why Is Rupert J. Handgretinger Influential?
(Suggest an Edit or Addition)Rupert J. Handgretinger's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 (2004) (1568)
- Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer (1998) (1414)
- Treating childhood acute lymphoblastic leukemia without cranial irradiation. (2009) (1051)
- Expression of therapeutic proteins after delivery of chemically modified mRNA in mice (2011) (591)
- T-helper-1-cell cytokines drive cancer into senescence (2013) (562)
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia. (2020) (449)
- Determinants of Antileukemia Effects of Allogeneic NK Cells 1 (2004) (430)
- Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. (1999) (410)
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. (2016) (409)
- Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation. (2010) (399)
- Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation (2006) (375)
- HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders. (2014) (362)
- Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group. (2009) (319)
- Megadose transplantation of purified peripheral blood CD34+progenitor cells from HLA-mismatched parental donors in children (2001) (290)
- Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells (2010) (281)
- Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. (2006) (249)
- Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. (2010) (239)
- Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? (2004) (234)
- Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation. (2013) (228)
- Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion. (2017) (225)
- A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. (1995) (215)
- Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT (1998) (204)
- Biology and Plasticity of CD133+ Hematopoietic Stem Cells (2003) (201)
- Susceptibility of multidrug-resistant human leukemia cell lines to human interleukin 2-activated killer cells. (1990) (189)
- Cidofovir for the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplant Patients (2006) (185)
- Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL (2002) (182)
- Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia. (2012) (179)
- Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. (2008) (175)
- Comparison of Killer Ig-Like Receptor Genotyping and Phenotyping for Selection of Allogeneic Blood Stem Cell Donors1 (2005) (168)
- Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells. (1991) (157)
- Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. (1999) (156)
- Pure red cell aplasia (2000) (152)
- Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update. (2008) (146)
- T‐cell alloreactivity dominates natural killer cell alloreactivity in minimally T‐cell‐depleted HLA‐non‐identical paediatric bone marrow transplantation (2003) (142)
- The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (141)
- Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia (2011) (138)
- Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children (1999) (137)
- Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma. (2004) (134)
- Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients (2015) (134)
- Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab (2014) (129)
- Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany (2020) (126)
- Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. (2014) (126)
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. (2014) (124)
- Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. (1995) (123)
- Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT. (2015) (122)
- Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. (2013) (122)
- Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. (2018) (121)
- High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. (2011) (120)
- Pure red-cell aplasia associated with clonal expansion of granular lymphocytes expressing killer-cell inhibitory receptors. (1999) (119)
- Long term outcome of high-risk neuroblastoma patients after immunotherapy with antibody ch14.18 or oral metronomic chemotherapy (2011) (118)
- Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study (2012) (118)
- Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. (2003) (118)
- Neutrophilic myeloid‐derived suppressor cells in cord blood modulate innate and adaptive immune responses (2013) (116)
- Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting (1998) (116)
- Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. (2007) (114)
- Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease (2013) (114)
- T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts (2016) (113)
- Anti-GD2 with an FC point mutation reduces complement fixation and decreases antibody-induced allodynia (2010) (112)
- Long-term outcome after haploidentical stem cell transplantation in children. (2004) (111)
- Transplantation of Megadoses of Purified Haploidentical Stem Cells (1999) (111)
- In vivo genome editing using nuclease-encoding mRNA corrects SP-B deficiency (2015) (111)
- Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia. (2003) (108)
- Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children (1997) (107)
- Human CD4+CD25+ Regulatory T Cells Share Equally Complex and Comparable Repertoires with CD4+CD25− Counterparts 1 (2004) (106)
- Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation (2005) (106)
- Exploitation of natural killer cells for the treatment of acute leukemia. (2016) (104)
- Modified Foxp3 mRNA protects against asthma through an IL-10-dependent mechanism. (2013) (103)
- Distribution of cell adhesion molecules in decidua of early human pregnancy. An immunohistochemical study. (1994) (103)
- The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse (2014) (102)
- Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. (2000) (102)
- Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors (2004) (101)
- A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen‐disparate haematopoietic stem cells from parental donors (2001) (101)
- Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective (2004) (101)
- Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia (2014) (99)
- Clinical Grade Generation of Hexon-specific T Cells for Adoptive T-cell Transfer as a Treatment of Adenovirus Infection After Allogeneic Stem Cell Transplantation (2008) (98)
- A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a (2005) (98)
- Rapid immune reconstitution after a reduced‐intensity conditioning regimen and a CD3‐depleted haploidentical stem cell graft for paediatric refractory haematological malignancies (2006) (97)
- Treatment of neuroblastoma stage 4 with 131I-meta-iodo-benzylguanidine, high-dose chemotherapy and immunotherapy. A pilot study. (1998) (93)
- Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. (2006) (91)
- A large-scale method for the selective depletion of αβ T lymphocytes from PBSC for allogeneic transplantation (2007) (89)
- Expression of mdrl, mrp, topoisomerase IIα/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias (1995) (89)
- Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. (1992) (88)
- Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. (2013) (86)
- Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. (2003) (85)
- Pathogenic Fungi Regulate Immunity by Inducing Neutrophilic Myeloid-Derived Suppressor Cells (2015) (85)
- A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. (2004) (83)
- Adenovirus infection after allogeneic stem cell transplantation (2007) (82)
- Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment (1999) (82)
- The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation (2019) (82)
- Long-Term Human CD34+ Stem Cell-Engrafted Nonobese Diabetic/SCID/IL-2Rγnull Mice Show Impaired CD8+ T Cell Maintenance and a Functional Arrest of Immature NK Cells (2010) (79)
- Purification of human natural killer cells using a clinical-scale immunomagnetic method. (2003) (78)
- Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. (2005) (78)
- Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T- and B-cell depleted grafts in children (2010) (77)
- Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells (2003) (76)
- A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. (2005) (76)
- Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis (2008) (76)
- Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects. (2006) (76)
- New approaches to graft engineering for haploidentical bone marrow transplantation. (2012) (75)
- Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma (2007) (75)
- Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. (1996) (73)
- Expression of checkpoint molecules on myeloid-derived suppressor cells. (2017) (72)
- Feasibility and Outcome of Reduced‐Intensity Conditioning in Haploidentical Transplantation (2007) (72)
- Presence of iron catalytic for free radical reactions in patients undergoing chemotherapy: implications for therapeutic management. (1995) (71)
- Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome. (2003) (70)
- Increased α2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells (2006) (69)
- The potential role of γδ T cells after allogeneic HCT for leukemia. (2018) (69)
- Haploidentical transplantation for acute lymphoblastic leukemia in childhood. (2004) (68)
- Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts (2011) (66)
- Characterization of lineage‐specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse (2000) (66)
- Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children (2002) (65)
- Negative depletion of CD3+ and TcR&agr;&bgr;+ T cells (2012) (64)
- Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation (2015) (64)
- Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. (1997) (63)
- Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity (2010) (63)
- Increased susceptibility of ifn‐γ‐treated neuroblastoma cells to lysis by lymphokine‐activated killer cells: Participation of ICAM‐1 induction on target cells (1991) (61)
- Inhibitory MHC class I receptors on γδ T cells in tumour immunity and autoimmunity (2000) (60)
- Haploidentical SCT in children: an update and future perspectives (2008) (60)
- Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features (2018) (60)
- Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (2018) (60)
- Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation (2012) (58)
- Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children. (2005) (58)
- H2O2-mediated Cytotoxicity of Pharmacologic Ascorbate Concentrations to Neuroblastoma Cells: Potential Role of Lactate and Ferritin (2006) (58)
- Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis (2013) (58)
- Adoptive transfer of pp 65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation (2010) (57)
- A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors (2003) (57)
- A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation. (2007) (57)
- High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa. (2015) (57)
- Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. (2004) (56)
- Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2020) (56)
- Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine. (2009) (56)
- Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo. (2015) (55)
- Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation (2012) (55)
- Brain parenchymal damage after haematopoietic stem cell transplantation for severe sickle cell disease (2005) (54)
- Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation (2015) (53)
- Comparative Analysis of the Immunophenotypes of Decidual and Peripheral Blood Large Granular Lymphocytes and T Cells During Early Human Pregnancy (1995) (53)
- The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia. (1995) (53)
- Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma. (1997) (52)
- The German National Registry of Primary Immunodeficiencies (2012–2017) (2019) (52)
- Surgical treatment of lung metastases in patients with embryonal pediatric solid tumors: an update. (2012) (52)
- A subset of CD56+ large granular lymphocytes in first-trimester human decidua are proliferating cells. (1999) (51)
- Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children (1999) (51)
- Immunological Aspects of Haploidentical Stem Cell Transplantation in Children (2001) (51)
- Circadian variations in the immunomodulatory role of the pineal gland (1988) (51)
- Comparison of itraconazole, voriconazole, and posaconazole as oral antifungal prophylaxis in pediatric patients following allogeneic hematopoietic stem cell transplantation (2013) (50)
- Monocyte-Induced Development of Th17 Cells and the Release of S100 Proteins Are Involved in the Pathogenesis of Graft-versus-Host Disease (2014) (48)
- Detection of circulating melanoma cells by immunomagnetic cell sorting (1999) (48)
- Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease. (2005) (48)
- Infants with stage 4 neuroblastoma: the impact of the chimeric anti-GD2-antibody ch14.18 consolidation therapy. (2005) (48)
- High Proportion of Leukemic Stem Cells at Diagnosis Is Correlated with Unfavorable Prognosis in Childhood Acute Myeloid Leukemia (2011) (48)
- Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1 (2014) (47)
- Outcome of hematopoietic stem cell transplantation for pediatric patients with therapy‐related acute myeloid leukemia or myelodysplastic syndrome (2006) (47)
- Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma (2002) (47)
- Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse? (1997) (47)
- Monocytes derived from humanized neonatal NOD/SCID/IL2Rγ(null) mice are phenotypically immature and exhibit functional impairments. (2012) (46)
- Interleukin-12- and interleukin-2-stimulated release of interferon-gamma by uterine CD56++ large granular lymphocytes is amplified by decidual macrophages. (1997) (46)
- Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery (2002) (46)
- Haploidentical Stem Cell Transplantation for Refractory/Relapsed Neuroblastoma. (2018) (46)
- Chronic Inflammatory Bowel Disease as Key Manifestation of Atypical ARTEMIS Deficiency (2010) (46)
- Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. (1996) (46)
- Extracorporeal photopheresis increases neutrophilic myeloid-derived suppressor cells in patients with GvHD (2014) (46)
- Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT (2019) (45)
- Total and active rabbit antithymocyte globulin (rATG;Thymoglobulin) pharmacokinetics in pediatric patients undergoing unrelated donor bone marrow transplantation. (2009) (45)
- Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia. (2009) (45)
- Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis (2018) (45)
- Combined PET/MR: Where Are We Now? Summary Report of the Second International Workshop on PET/MR Imaging April 8–12, 2013, Tubingen, Germany (2014) (45)
- Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. (1999) (45)
- Human γδ T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells (2000) (45)
- Follow-up in Neuroblastoma: Comparison of Metaiodobenzylguanidine and a Chimeric Anti-GD2 Antibody for Detection of Tumor Relapse and Therapy Response (2001) (44)
- Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis (2010) (44)
- Dendritic cells: functional aspects of glycosylation and lectins. (2009) (44)
- Intensity of HLA class I expression and KIR‐mismatch determine NK‐cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia (2007) (44)
- EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia (2013) (44)
- Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma. (1998) (43)
- Combination Immunotherapy with Clinical-Scale Enriched Human γδ T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma (2005) (43)
- A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells (2002) (43)
- Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort (2013) (43)
- The decidua of early human pregnancy: immunohistochemistry and function of immunocompetent cells. (1992) (41)
- Engraftment of low numbers of pediatric acute lymphoid and myeloid leukemias into NOD/SCID/IL2Rcγnull mice reflects individual leukemogenecity and highly correlates with clinical outcome (2013) (41)
- Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. (2006) (40)
- Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors (2018) (39)
- γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay (2014) (39)
- Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia (2004) (39)
- Distribution of cell adhesion molecules on CD56++, CD3-, CD16- large granular lymphocytes and endothelial cells in first-trimester human decidua. (1993) (38)
- Collagen VII Half-Life at the Dermal-Epidermal Junction Zone: Implications for Mechanisms and Therapy of Genodermatoses. (2016) (38)
- KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts (2014) (38)
- Nephron sparing surgery for synchronous bilateral nephroblastoma involving the renal hilus. (2011) (38)
- Flow cytometry with anti HLA-antibodies: a simple but highly sensitive method for monitoring chimerism and minimal residual disease after HLA-mismatched stem cell transplantation (2007) (37)
- Mediation of human NK-activity by components in extracts of Viscum album. (1987) (37)
- Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases (2004) (37)
- Improved Immune Recovery after Transplantation of TCRαβ/CD19 Depleted Allografts from Haploidentical Donors in Pediatric Patients (2014) (37)
- Unrelated peripheral blood stem cell transplantation with ‘megadoses’ of purified CD34+ cells in three children with refractory severe aplastic anemia (2000) (37)
- Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects (2003) (37)
- Phenotype and function of human natural killer cells purified by using a clinical-scale immunomagnetic method (2005) (37)
- Caspofungin as antifungal prophylaxis in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis (2012) (36)
- Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate. (2001) (36)
- Uterine granular lymphocytes are activated natural killer cells expressing VLA-1. (1992) (36)
- Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002. (2007) (36)
- Human gammadelta T lymphocytes exert natural and IL-2-induced cytotoxicity to neuroblastoma cells. (2000) (36)
- Haploidentical stem cell transplantation for children with high‐risk leukemia (2012) (35)
- Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia (2015) (35)
- Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS (2021) (35)
- In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients. (2006) (35)
- Establishment and characterization of a cell line (Wa-2) derived from an extrarenal rhabdoid tumor. (1990) (35)
- Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo (2017) (34)
- Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis. (2002) (34)
- Cytogenetic evolution of MYCN and MDM2 amplification in the neuroblastoma LS tumour and its cell line. (1995) (34)
- New strategies for haploidentical transplantation (2012) (34)
- Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction. (2005) (34)
- Chronic graft-versus-host-disease in CD34(+)-humanized NSG mice is associated with human susceptibility HLA haplotypes for autoimmune disease. (2015) (33)
- GD2-targeted chimeric antigen receptor T cells prevent metastasis formation by elimination of breast cancer stem-like cells (2019) (33)
- Clinical strategies for the treatment of neuroblastoma. (1995) (33)
- Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. (2005) (33)
- Influence of Dichloroacetate (DCA) on Lactate Production and Oxygen Consumption in Neuroblastoma Cells: Is DCA a Suitable Drug for Neuroblastoma Therapy? (2012) (33)
- CD34+ selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantation (2018) (33)
- Ep‐CAM in malignant liver tumours (2000) (33)
- Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation (2017) (32)
- Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity. (2006) (32)
- Etiology and Outcome of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant Recipients (2003) (32)
- Expression of CD44 isoforms by highly enriched CD34-positive cells in cord blood, bone marrow and leukaphereses (1997) (31)
- Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation (2005) (30)
- Haploidentical stem cell transplantation in DOCK8 deficiency - Successful control of pre-existing severe viremia with a TCRaß/CD19-depleted graft and antiviral treatment. (2014) (30)
- Blinatumomab in pediatric patients with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia (2020) (30)
- A Phase 1/2 Study Of Blinatumomab In Pediatric Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (2013) (30)
- Increased alpha2,6-sialylation of surface proteins on tolerogenic, immature dendritic cells and regulatory T cells. (2006) (30)
- Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news? (2003) (30)
- Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia (2019) (30)
- Uptake of mIBG and catecholamines in noradrenaline- and organic cation transporter-expressing cells: potential use of corticosterone for a preferred uptake in neuroblastoma- and pheochromocytoma cells. (2009) (29)
- Human γδ T Cells From G-CSF-Mobilized Donors Retain Strong Tumoricidal Activity and Produce Immunomodulatory Cytokines After Clinical-Scale Isolation (2005) (29)
- Immune Response of Human Propagated γδ-T-Cells to Neuroblastoma Recommend the Vδ1+ Subset for γδ-T-cell–based Immunotherapy (2008) (29)
- Mesenchymal stromal cells: a novel treatment option for steroid-induced avascular osteonecrosis. (2008) (28)
- Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells (2008) (28)
- Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis (2004) (28)
- Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report (2018) (28)
- Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells (2020) (28)
- Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19 (2021) (27)
- High frequency of immature cells at diagnosis predicts high minimal residual disease level in childhood acute lymphoblastic leukemia. (2010) (27)
- Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients. (1991) (27)
- Cytolytic activity of NK cell clones against acute childhood precursor-B-cell leukaemia is influenced by HLA class I expression on blasts and the differential KIR phenotype of NK clones (2009) (27)
- Expression of an early myelopoietic antigen (CD33) on a subset of human umbilical cord blood-derived natural killer cells. (1993) (27)
- In melanoma, Hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival (2014) (27)
- Mastocytosis: reactive or neoplastic? (1997) (27)
- Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice. (2010) (26)
- Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemia (2007) (26)
- Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation (2000) (26)
- The history and future prospective of haplo-identical stem cell transplantation. (2008) (26)
- Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (2014) (26)
- Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer (2021) (26)
- Comparison of different adjuvant radiotherapy approaches in childhood bladder/prostate rhabdomyosarcoma treated with conservative surgery (2011) (26)
- A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants. (2015) (26)
- Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin (2020) (26)
- Combination immunotherapy with clinical-scale enriched human gammadelta T cells, hu14.18 antibody, and the immunocytokine Fc-IL7 in disseminated neuroblastoma. (2005) (25)
- Phase 1/2 Study in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Receiving Blinatumomab Treatment (2014) (25)
- CD133-Positive Hematopoietic Stem Cells: From Biology to Medicine. (2013) (25)
- Outcome of allogeneic stem cell transplantation in children with non-malignant diseases. (2006) (25)
- Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tübingen, Germany. (2007) (24)
- Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. (1995) (24)
- Transplantation of highly purified CD34+ progenitor cells from alternative donors in children with refractory severe aplastic anaemia (2004) (24)
- Adapter chimeric antigen receptor (AdCAR)-engineered NK-92 cells: an off-the-shelf cellular therapeutic for universal tumor targeting (2020) (24)
- Clinical utility of computed tomography screening of chest, abdomen, and sinuses before hematopoietic stem cell transplantation: the St. Jude experience. (2009) (24)
- Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation (2018) (24)
- Expression analysis of multidrug resistance associated genes in neuroblastomas. (1999) (24)
- Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. (2008) (24)
- Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. (2004) (24)
- IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT (2012) (23)
- Treatment of graft failure with TNI‐based reconditioning and haploidentical stem cells in paediatric patients (2016) (23)
- Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study (2017) (23)
- Cytogenetic and molecular characterization of a newly established neuroblastoma cell line LS (1991) (23)
- Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations. (2006) (23)
- NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML (2015) (23)
- Allo-SCT using BU, CY and melphalan for children with AML in second CR (2013) (23)
- Tumor-priming converts NK cells to memory-like NK cells (2017) (22)
- Resistance to methotrexate and multidrug resistance in childhood malignancies. (1989) (22)
- Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin (1998) (22)
- Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity (2017) (22)
- Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children (2006) (22)
- Chorein addiction in VPS13A overexpressing rhabdomyosarcoma cells (2015) (22)
- Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models (2016) (22)
- Haploidentical transplantation: the search for the best donor. (2014) (21)
- Immunohistochemical and cytogenetic findings in malignant rhabdoid tumor. (1996) (21)
- Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood. (1993) (21)
- Cellular immune reconstitution after haploidentical transplantation in children. (2008) (20)
- Autologous transplantation of CD133 selected hematopoietic progenitor cells for treatment of relapsed acute lymphoblastic leukemia (2007) (20)
- Both mature KIR+ and immature KIR- NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdcscid IL2rgtmWjl/Sz mice. (2014) (20)
- Impaired tumor rejection by memory CD8 T cells in mice with NKG2D dysfunction (2012) (20)
- Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantation. (1999) (20)
- Ex vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation. (2010) (19)
- Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors. (2011) (19)
- Targeting hedgehog signalling by arsenic trioxide reduces cell growth and induces apoptosis in rhabdomyosarcoma. (2016) (19)
- Allogeneic graft‐versus‐hepatoblastoma effect (2006) (19)
- LMO2 activation by deacetylation is indispensable for hematopoiesis and T-ALL leukemogenesis. (2019) (19)
- Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient. (2009) (19)
- Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen (2003) (19)
- Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma (2015) (19)
- Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy (2019) (19)
- KIR-incompatible hematopoietic-cell transplantation for poor prognosis infant acute lymphoblastic leukemia. (2006) (18)
- Posaconazole plasma concentration in pediatric patients receiving antifungal prophylaxis after allogeneic hematopoietic stem cell transplantation. (2016) (18)
- Cytological and molecular remissions with blinatumomab treatment in second or later bone marrow relapse in pediatric acute lymphoblastic leukemia (ALL). (2013) (18)
- Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A‐deficient immortalized mesenchymal stromal cells (2017) (18)
- Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic cells. (2006) (18)
- Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies (2015) (18)
- Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy (2015) (18)
- Human gammadelta T cells from G-CSF-mobilized donors retain strong tumoricidal activity and produce immunomodulatory cytokines after clinical-scale isolation. (2005) (18)
- CRISPR/Cas9-modified hematopoietic stem cells—present and future perspectives for stem cell transplantation (2019) (18)
- Point-counterpoint: haploidentical family donors versus cord blood transplantation. (2011) (18)
- Five donors–one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors (2008) (17)
- Nifurtimox reduces N-Myc expression and aerobic glycolysis in neuroblastoma (2015) (17)
- Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children. (2011) (17)
- Dendritic cell vaccination in an allogeneic stem cell recipient receiving a transplant from a human cytomegalovirus (HCMV)-seronegative donor: induction of a HCMV-specific T(helper) cell response. (2010) (17)
- OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. (2000) (17)
- Human Peripheral CD4+ Vδ1+ γδT Cells Can Develop into αβT Cells (2014) (17)
- Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy. (2019) (17)
- mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo (2016) (17)
- Interferon-gamma upregulates the susceptibility of human neuroblastoma cells to interleukin-2-activated natural killer cells. (1989) (17)
- Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae (2019) (17)
- Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis. (2003) (17)
- Staphylococcal Enterotoxins Dose-Dependently Modulate the Generation of Myeloid-Derived Suppressor Cells (2018) (17)
- Patterns of monocyte subpopulations and their surface expression of HLA-DR during adverse events after hematopoietic stem cell transplantation (2015) (16)
- WT1 protein expression in childhood acute leukemia (2008) (16)
- Characterisation of the Cell Line HC-AFW1 Derived from a Pediatric Hepatocellular Carcinoma (2012) (16)
- Influence of a mutation in IFN-γ receptor 2 (IFNGR2) in human cells on the generation of Th17 cells in memory T cells. (2013) (16)
- One goal, different strategies – molecular and cellular approaches for the treatment of inherited skin fragility disorders (2013) (16)
- Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody. (2016) (16)
- Positive selection of CD56+ lymphocytes by magnetic cell sorting. (1996) (16)
- Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia. (2005) (16)
- Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing’s sarcoma patients (2015) (16)
- A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19 (2021) (16)
- Malignant infantile osteopetrosis & primary pulmonary hypertension: A new combination? (2004) (16)
- Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization. (1995) (16)
- Haploidentical hematopoietic cell transplantation using in vitro T cell depleted grafts as salvage therapy in patients with disease relapse after prior allogeneic transplantation (2017) (15)
- Possible allogeneic graft-versus-tumor effect in childhood melanoma. (2003) (15)
- Combined application of arsenic trioxide and lithium chloride augments viability reduction and apoptosis induction in human rhabdomyosarcoma cell lines (2017) (15)
- In vitro induction of lymphokine-activated killer (LAK) activity in patients with neuroblastoma. (1989) (15)
- Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis (2022) (15)
- Evidence for a lymphotropic nature of circulating plasmacytoid monocytes: findings from a case of CD56+ chronic myelomonocytic leukemia (1995) (14)
- Phagocytic activity of monocytes, their subpopulations and granulocytes during post-transplant adverse events after hematopoietic stem cell transplantation. (2015) (14)
- CD276 as a novel CAR NK‐92 therapeutic target for neuroblastoma (2020) (14)
- Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia (2016) (14)
- G‐CSF administration prior to donor lymphocyte apheresis promotes anti‐leukaemic effects in allogeneic HCT patients (2019) (14)
- Activation of cellular cytotoxicity and complement-mediated lysis of melanoma and neuroblastoma cells in vitro by murine antiganglioside antibodies MB 3.6 and 14.G2a (1994) (14)
- Increase of Intermediate Monocytes in Graft-versus-Host Disease: Correlation with MDR1+Th17.1 Levels and the Effect of Prednisolone and 1α,25-Dihydroxyvitamin D3. (2017) (14)
- Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes (2016) (13)
- Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients (2021) (13)
- Haploidentical stem cell transplantation and subsequent immunotherapy with antiGD2 antibody for patients with relapsed metastatic neuroblastoma. (2015) (13)
- Negative depletion of CD3(+) and TcR alpha beta(+) T cells (2012) (13)
- Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial (2019) (13)
- CRISPR/Cas9 technology: towards a new generation of improved CAR-T cells for anticancer therapies. (2019) (13)
- Antiviral activity against CMV-infected fibroblasts in pediatric patients transplanted with CD34(+)-selected allografts from alternative donors. (2004) (13)
- Drug-induced changes in the expression of MDR-associated genes: Investigations on cultured cell lines and chemotherapeutically treated leukemias (2005) (13)
- Transplantation of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors: Robust Engraftment and Rapid Immune Reconstitution In Children with High Risk Leukemia (2011) (13)
- Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies. (2008) (13)
- Outcomes of pediatric identical living‐donor liver and hematopoietic stem cell transplantation (2016) (12)
- Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia (2013) (12)
- Phase 1/2 KEYNOTE-051 study of pembrolizumab (pembro) in pediatric patients (pts) with advanced melanoma or a PD-L1+ advanced, relapsed, or refractory solid tumor or lymphoma. (2017) (12)
- Haploidentical Stem Cell Transplantation with CD3 Depleted Mobilized Peripheral Blood Stem Cell Grafts for Children with Hematologic Malignancies. (2005) (12)
- Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG. (1994) (12)
- Hematopoietic stem cell gene therapy: The optimal use of lentivirus and gene editing approaches. (2019) (12)
- Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells (1995) (12)
- Mismatched Family Member Donor Transplantation for Patients with Refractory Hematologic Malignancies: Long-Term Followup of a Prospective Clinical Trial. (2006) (12)
- A novel approach for the analysis of T-cell reconstitution by using a T-cell receptor beta-based oligonucleotide microarray in hematopoietic stem cell transplantation. (2007) (12)
- Inadvertent intravenous administration of maternal breast milk in a six-week-old infant: a case report and review of the literature (2014) (12)
- Bacterial reprogramming of PBMCs impairs monocyte phagocytosis and modulates adaptive T cell responses (2012) (12)
- Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation (2009) (12)
- Stem Cell Transplantation (2013) (11)
- Ferritin as an early marker of graft rejection after allogeneic hematopoietic stem cell transplantation in pediatric patients (2015) (11)
- Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients (2015) (11)
- Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014. (2016) (11)
- Inhibitory MHC class I receptors on gammadelta T cells in tumour immunity and autoimmunity. (2000) (11)
- Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation (2015) (11)
- 1008PDZUMA-4 preliminary results: phase 1 study of KTE-C19 chimeric antigen receptor T cell therapy in pediatric and adolescent patients (pts) with relapsed/refractory acute lymphoblastic leukemia (R/R ALL) (2017) (11)
- OKT‐3‐based reconditioning regimen for early graft failure in HLA‐non‐identical stem cell transplants (2000) (11)
- Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany. (2009) (11)
- Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells. (2004) (11)
- Immunotargeting relapsed or refractory precursor B-cell acute lymphoblastic leukemia – role of blinatumomab (2017) (11)
- Isolation and phenotypic characterization of CD117-positive cells. (1996) (11)
- Lysis of neuroblastoma cells by the ADCC-reaction: granulocytes of patients with chronic granulomatous disease are more effective than those of healthy donors. (1989) (11)
- CD155 is involved in NK-cell mediated lysis of human hepatoblastoma in vitro. (2011) (11)
- WT1 protein expression in slowly proliferating myeloid leukemic cell lines is scarce throughout the cell cycle with a minimum in G0/G1 phase. (2008) (11)
- Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor and Molecularly Resistant Acute Lymphoblastic Leukemia (R/R ALL): Updated Analysis of 110 Patients Treated in an Expanded Access Study (RIALTO) (2019) (11)
- CD34 stem cell dose and development of extensive chronic graft-versus-host disease. (2002) (11)
- Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model (2016) (11)
- Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago (2004) (10)
- Allogenic peripheral blood stem cell (PBSC) transplantation in two patients with graft failure. (1995) (10)
- Effects of granulocytes on human neuroblastoma cells measured by chemiluminescence and chromium-51 release assay. (1989) (10)
- Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III. (2021) (10)
- Successful treatment of primary refractory acute myeloid leukemia with megadose stem cell transplantation, bone marrow boost and reduced intensity conditioning avoiding chronic graft vs. host disease and severe late toxicity (2003) (10)
- Will post-transplantation cell therapies for pediatric patients become standard of care? (2015) (10)
- Consensus of German Transplant Centers on Hematopoietic Stem Cell Transplantation in Fanconi Anemia (2015) (10)
- Immunotherapy in the context of hematopoietic stem cell transplantation: the emerging role of natural killer cells and mesenchymal stromal cells. (2010) (10)
- Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor. (1994) (10)
- Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotherapy. (1994) (10)
- Novel adapter CAR-T cell technology for precisely controllable multiplex cancer targeting (2020) (9)
- Bone marrow-derived factors support growth of N-type, but not of melanocytic neuroblastoma cells. (2002) (9)
- Application of the murine anti-Gd-2 antibody 14.Gd-2a for diagnosis and therapy of neuroblastoma. (1991) (9)
- Glycosylation and lectins-examples of immunesurveillance and immune evasion. (2004) (9)
- Defibrotide for the treatment of PIMS-TS in two pediatric patients. (2020) (9)
- TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: First Results of a Prospective Multicenter Phase I/II Clinical Trial (2016) (9)
- Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner (2019) (9)
- In Vitro Evaluation of CD276-CAR NK-92 Functionality, Migration and Invasion Potential in the Presence of Immune Inhibitory Factors of the Tumor Microenvironment (2021) (9)
- Chapter 15 Potential of genetically engineered anti-ganglioside GD2 antibodies for cancer immunotheraphy (1994) (9)
- Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment (2021) (9)
- Siglec‐7 tetramers characterize B‐cell subpopulations and leukemic blasts (2012) (9)
- Reduction of N-myc expression by antisense RNA is amplified by interferon: possible involvement of the 2-5A system. (1990) (9)
- Induction of Thelper1-driven Antiviral T-cell Lines for Adoptive Immunotherapy Is Determined by Differential Expression of IFN-&ggr; and T-cell Activation Markers (2012) (9)
- A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up (2012) (9)
- Improved selectivity of mIBG uptake into neuroblastoma cells in vitro and in vivo by inhibition of organic cation transporter 3 uptake using clinically approved corticosteroids. (2016) (9)
- Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas. (2016) (8)
- Selection of Stem Cells by Using Antibodies That Target Different CD34 Epitopes Yields Different Patterns of T‐Cell Differentiation (2007) (8)
- Human leukocyte antigen DR surface expression on CD14+ monocytes during adverse events after hematopoietic stem cell transplantation (2015) (8)
- EBV lymphoproliferative disease of host origin after haploidentical stem cell transplantation (2007) (8)
- Identification of fatal outcome in a childhood nasopharyngeal carcinoma patient by protein expression profiling. (2018) (8)
- Combinatorial Targeting of Multiple Shared Antigens By Adapter-CAR-T Cells (aCAR-Ts) Allows Target Cell Discrimination and Specific Lysis Based on Differential Expression Profiles (2018) (8)
- TRANSPLANTATION Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion (2017) (8)
- T cell depletion A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells (2002) (8)
- Simultaneous Resection of High-risk Liver Tumors and Pulmonary Metastases in Children. (2015) (8)
- Children with Relapsed or Refractory Nephroblastoma: Favorable Long-term Survival after High-dose Chemotherapy and Autologous Stem Cell Transplantation (2014) (7)
- A newborn with grouped facial skin lesions and subsequent seizures (2014) (7)
- CD3 Depleted Hematopoietic Peripheral Blood Stem Cell Grafts in Children with Refractory Hematologic Malignancies Undergoing Transplantation from Mismatched Related Donors. (2005) (7)
- Surgical management of stem cell transplantation‐related complications in children (2012) (7)
- Synthesis and biological effects of new hybrid compounds composed of benzylguanidines and the alkylating group of busulfan on neuroblastoma cells. (2014) (7)
- Emerging role of immunotherapy for childhood cancers. (2018) (7)
- Safety and Efficacy of Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning in Children: Results of a Prospective Multicenter Phase I/II Clinical Trial (2017) (7)
- Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature (2019) (7)
- Positive Selection of Hematopoietic Progenitor Cells for Autologous and Allogeneic Transplantation in Pediatric Patients with Solid Tumors and Leukemia (2000) (7)
- Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia. (1995) (7)
- Rhodamine 123-efflux from hematopoietic subpopulations and leukaemic blast populations marked by PerCP-conjugated monoclonal antibodies. (1996) (7)
- A novel anti-GD2 monoclonal antibody (mAb), hu14.18K322A, in children with refractory or recurrent neuroblastoma: Early-phase evaluation. (2011) (7)
- Phenotypic and functional characterization of mobilized peripheral blood CD34+ cells coexpressing different levels of c-Kit. (1998) (7)
- Human T cells modulate myeloid-derived suppressor cells through a TNF-α-mediated mechanism. (2018) (7)
- Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study (2021) (7)
- Long-Term Remission After First-Line Single-Agent Treatment with Arsenic Trioxide of Relapsed Acute Promyelocytic Leukemia in an 8-Year-Old Boy (2011) (7)
- Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports) (2019) (7)
- Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol (2022) (7)
- Blinatumomab use in pediatric patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL) from an open-label, multicenter, expanded access study. (2017) (6)
- Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4 (2021) (6)
- KIR B haplotype donors confer a reduced risk of relapse after haploidentical transplantation in children with acute lymphoblastic leukemia (2014) (6)
- Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting. (2009) (6)
- In vitro and in vivo effect of interleukin-2 on the 2',5'-oligoadenylate synthetase activity of peripheral mononuclear blood cells. (1990) (6)
- Enriched Bone Marrow Derived Disseminated Neuroblastoma Cells Can Be a Reliable Source for Gene Expression Studies—A Validation Study (2015) (6)
- Preemptive administration of human αβ T cell receptor-targeting monoclonal antibody GZ-αβTCR potently abrogates aggressive graft-versus-host disease in vivo (2015) (6)
- Characterization of monocyte subtypes regarding their phenotype and development in the context of graft-versus-host disease. (2018) (6)
- Adapter Chimeric Antigen Receptor (aCAR)-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Universal Tumor Targeting (2018) (6)
- Isolation, molecular cloning and in vitro expression of rhesus monkey (Macaca mulatta) prominin-1.s1 complementary DNA encoding a potential hematopoietic stem cell antigen. (2006) (6)
- 131I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors (2021) (6)
- Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients (2019) (6)
- Highlights of the Second International Conference on “Immunotherapy in Pediatric Oncology” (2011) (6)
- ADCC can improve graft vs leukemia effect after T- and B-cell depleted haploidentical stem cell transplantation in pediatric B-lineage ALL (2019) (5)
- Bone Marrow-Derived Stem Cells Migrate into Intraepidermal Skin Defects of a Desmoglein-3 Knockout Mouse Model but Preserve their Mesodermal Differentiation. (2017) (5)
- [Differential diagnosis of childhood osteomyelitis--classification according to scintigraphic, radiologic and magnetic resonance tomographic characteristics]. (1996) (5)
- Diagnostic challenge in recurrent skin rash after autologous bone marrow transplantation. (2006) (5)
- Longtime outcome after intraosseous application of autologous mesenchymal stromal cells in pediatric patients and young adults with avascular necrosis after steroid or chemotherapy. (2020) (5)
- Unrelated partially matched peripheral blood stem cell transplantation with highly purified CD34+ cells in a child with Wiskott–Aldrich syndrome (2000) (5)
- Monocytes show immunoregulatory capacity on CD4+ T cells in a human in‐vitro model of extracorporeal photopheresis (2018) (5)
- How an accidental discovery paved the way for the treatment of complicated infantile haemangiomas (2014) (5)
- Fast enzymatic synthesis of n.c.a. 6-[18 F]fluorodopamine (FDA) from n.c.a. 6-[18 F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptake. (2019) (5)
- Fulminant Rhizomucor pusillus mucormycosis during anti-leukemic treatment with blinatumomab in a child: A case report and review of the literature (2020) (5)
- Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2021) (5)
- [The role of interferons in neuroblastoma. 2: Immunomodulatory effects]. (1990) (5)
- Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha. (2004) (5)
- Modified hCFTR mRNA restores normal lung function in a mouse model of cystic fibrosis (2017) (5)
- Rapid conversion to full chimerism after reduced intensity conditioning (RIC) and transplantation of T-cell depleted large numbers of CD34+ stem and CD56+ natural killer (NK) cells obtained from mobilized haploidentical donors (2004) (5)
- Molecular monitoring of immune reconstitution after haploidentical stem cell transplantation. (2008) (5)
- Extended hepatic resection in advanced hepatoblastoma. (2012) (5)
- No association between the presence of killer-cell immunoglobulin-like receptor genes and susceptibility to childhood ALL. (2015) (5)
- Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients (2020) (5)
- Matched versus Haploidentical Hematopoietic Stem Cell Transplantation as Treatment Options for Primary Immunodeficiencies in Children. (2020) (5)
- Leucoencephalopathy, Transverse Myelopathy, and Peripheral Neuropathy in Association With Glutamic Acid Decarboxylase-65 (GAD) Antibodies in Children With Cancer (2008) (5)
- Ex vivo expansion of autologous, donor-derived NK-, γδT-, and cytokine induced killer (CIK) cells post haploidentical hematopoietic stem cell transplantation results in increased antitumor activity (2019) (5)
- Bone marrow transplantation in children with neuroblastoma. (1989) (5)
- Immunosuppressive Total Nodal Irradiation-Based Reconditioning Regimens After Graft Rejection or Graft Failure in Pediatric Patients Treated With Myeloablative Allogeneic Hematopoietic Cell Transplantation. (2019) (5)
- A novel approach for quantification of KIR expression in healthy donors and pediatric recipients of hematopoietic SCTs (2009) (5)
- Blinatumomab in Children with Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R-ALL): Final Results of 110 Patients Treated in an Expanded Access Study (RIALTO) (2020) (4)
- Long-term follow-up after the application of mesenchymal stromal cells in children and adolescents with steroid-refractory graft-versus-host disease. (2021) (4)
- Application of interleukin 2 in neuroblastoma. (1987) (4)
- A Mutation-Agnostic Hematopoietic Stem Cell Gene Therapy for Metachromatic Leukodystrophy. (2021) (4)
- Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile (2020) (4)
- CD3+ T cells in first-trimester decidua. (1994) (4)
- Expression of KIR2DS1 does not significantly contribute to NK cell cytotoxicity in HLA-C1/C2 heterozygous haplotype B donors (2017) (4)
- Transplantation Of TcRαβ/CD19 Depleted Stem Cells From Haploidentical Donors In Children: Current Results (2013) (4)
- Treatment of liver transplant graft-versus-host disease with antibodies against tumor necrosis factor-α. (2012) (4)
- No difference in survival after HLA mismatched versus HLA matched allogeneic stem cell transplantation in Ewing sarcoma patients with advanced disease (2021) (4)
- Selective, efficient modulation of activated CD4+ αβT cells by the novel humanized antibody GZ-αβTCR targeting human αβTCR (2015) (4)
- Arsenic trioxide in pediatric cancer – a case series and review of literature (2021) (4)
- Donor selection for AML: do the KIR. (2010) (4)
- ZUMA-4: A phase 1/2 multicenter study evaluating the safety and efficacy of KTE-C19 (anti-CD19 CAR T cells) in pediatric and adolescent subjects with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL). (2016) (4)
- Efficacy, Safety And Feasibility Of Antiemetic Prophylaxis With Fosaprepitant, Granisetron And Dexamethasone In Pediatric Patients With Hemato-Oncological Malignancies (2019) (4)
- Levels of Total Fungus and Aspergillus on a Pediatric Hematopoietic Stem Cell Transplant Unit (2004) (4)
- Adapter Chimeric Antigen Receptor (AdCAR)-Engineered NK-92 Cells for the Multiplex Targeting of Bone Metastases (2021) (4)
- Results of a Phase II Study of Haploidentical Hematopoietic Cell Transplantation (HHCT) in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Clinical Outcome and Immune Reconstitution. (2009) (4)
- Somatic Reversion of a Novel IL2RG Mutation Resulting in Atypical X-Linked Combined Immunodeficiency (2021) (4)
- Summary of Symposium: The Future of Stem Cell Transplantation for Sickle Cell Disease (2002) (3)
- Cell adhesion molecules on large granular lymphocytes and endothelial cells in decidua of early human pregnancy (2004) (3)
- The efficiency of a new cell separation technique in bone marrow purging without damaging the purged tumor cells. (1990) (3)
- High Molecular Remission Rate in Pediatric Patients (pts) with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (r/r ALL) Treated with Blinatumomab: Rialto an Open-Label, Multicenter, Expanded Access Study (2018) (3)
- The age of stored erythrocytes influences methaemoglobin formation when circulated in a heart-lung machine model. (2018) (3)
- Adoptive Transfer of EBNA1-Specific T-Cells as a Treatment of Epstein-Barr-Virus Reactivation Following Allogeneic Stem Cell Transplantation (2010) (3)
- Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors. (1994) (3)
- Therapy Response Correlates with ALDH Activity in ALDH Low-Positive Childhood Acute Lymphoblastic Leukemias (2014) (3)
- MEETING REPORT Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 2930 September 2006, Tubingen, Germany (2007) (3)
- Abstract A013: Haploidentical stem cell transplantation and subsequent immunotherapy with antiGD2 antibody for patients with relapsed metastatic neuroblastoma (2019) (3)
- Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL (2022) (3)
- Haploidentical Transplantation (2018) (3)
- Gene therapy for severe combined immunodeficiency disease. (2002) (3)
- Arginase 1+ IL‐10+ polymorphonuclear myeloid‐derived suppressor cells are elevated in patients with active pemphigus and correlate with an increased Th2/Th1 response (2021) (3)
- Peripheral stem cell collection and transplantation in pediatric patients. (1992) (3)
- Expression of GD3 disialoganglioside antigen on peripheral T‐lymphocytes in patients with disseminated malignant melanoma (1997) (3)
- CD133+ Hematopoietic Cells Successfully Reconstitute Hematopoiesis Following Autologous Peripheral Blood Stem Cell Transplantation. (2004) (3)
- Immune monitoring and TCR sequencing of CD4 T cells in a long term responsive patient with metastasized pancreatic ductal carcinoma treated with individualized, neoepitope-derived multipeptide vaccines: a case report (2018) (3)
- Association analysis between SUFU polymorphism rs17114808 and acute graft versus host disease after hematopoietic stem cell transplantation (2018) (3)
- Germline Genetic Variation in IKZF1 and Predisposition to Childhood Acute Lymphoblastic Leukemia (2015) (3)
- Hematopoietic Stem Cell Transplantation For Patients With Autosomal Recessive Complete Interferon Gamma Receptor 2 Deficiency: Experience In Oman. (2021) (3)
- Case report 756 (2004) (3)
- Interaction of arsenic trioxide and etoposide in Ewing sarcoma cell lines. (2019) (3)
- Partial break in tolerance of NKG2A−/LIR-1− single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation (2017) (3)
- A simple assay for determination of iron release from ferritin in neuroblastoma cells. (1992) (3)
- Role of cell adhesion molecules in implantation. (1995) (3)
- Favorable immune recovery and low rate of GvHD in children transplanted with partially T cell-depleted PBSC grafts (2018) (3)
- A functional inflammasome activation assaydifferentiates patients with pathogenic NLRP3mutations and symptomatic patients with lowpenetrance variants (2015) (3)
- Preservation of immune repertoire by selective depletion of haploidentical grafts. (2010) (3)
- RNA ImmunoGenic Assay: Simple method for detecting immunogenicity of in vitro transcribed mRNA (2020) (2)
- Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma – a case report (2020) (2)
- Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation (2014) (2)
- Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults Using Reduced Intensity Conditioning and CD3/CD19-Depleted Grafts: Interim Analysis of a Phase I/II Study. (2008) (2)
- Cyclophosphamide and targeted dose topotecan with autologous hematopoietic stem cell rescue for solid tumors. (2004) (2)
- Low Transplant Related Toxicity and Mortality after Transplantation of CD3/CD19 Depleted Haploidentical Stem Cells with Reduced Intensity Conditioning in Children. (2007) (2)
- Comparative analysis of lentiviral gene transfer approaches designed to promote fetal hemoglobin production for the treatment of β-hemoglobinopathies. (2020) (2)
- Haploidentical Stem Cell Transplantation in Children: A Comparison between Positive Selection of Stem Cells and Depletion of T- and B-Cells. (2005) (2)
- Both mature KIR and immature KIR NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc IL2rg/Sz mice (2014) (2)
- First Results of a Prospective Multicenter Phase I/II Clinical Trial in Adult Patients Using Tcralpha/Beta and CD19 Depleted Haploidentical Stem Cell Transplantation Following Reduced Intensity Conditioning (2017) (2)
- [The role of interferons in neuroblastoma. 1: Antiproliferative effects]. (1990) (2)
- Transplantation of CD34+ enriched allografts in children with nonmalignant diseases: does graft manipulation necessarily result in high incidence of graft failure? (2004) (2)
- Removal of CD276+ cells from haploidentical memory T-cell grafts significantly lowers the risk of GVHD (2021) (2)
- Abstract B124: Personalized peptide vaccination based on patient-individual tumor-specific variants induces T-cell responses in pediatric patients (2019) (2)
- Novel Adapter Chimeric Antigen Receptor (aCAR) T Cells for Temporally Controllable Targeting of Single and Multiple Tumor Antigens (2017) (2)
- Haploidentical stem cell transplantation in children: Improved engraftment and immune recovery after depletion of T and B cells instead of positive selection of stem cells? (2006) (2)
- Interventional Intensification of Chemotherapy Prior to Hematopietic Stem Cell Transplantation Reduces Residual Leukemia but Does Not Improve Survival in Children with Relapsed Acute Lymphoblastic Leukemia (2014) (2)
- A chimeric CD 19 antibody mediates cytotoxic activity against leukemic blasts with effectors from pediatric patients transplanted with T cell depleted allografts (2004) (2)
- A New Conditioning Regimen with Clofarabine for Allogeneic Stem Cell Transplantation in Pediatric Patients with Refractory Disease. (2007) (2)
- Dose Reduced Conditioning and CD3/CD19 Depletion for Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults: Fast Engraftment and Low Toxicity. (2005) (2)
- CAReful epitope selection matters. (2013) (2)
- Cyclophosphamide and targeted dose topotecan with autologous hematopoietic stem cell rescue for solid tumors (2004) (2)
- Effect of the HDAC Inhibitor SAHA on the Immunmodulatory Properties of MSC and Tumor Stroma Cells. (2010) (2)
- More or less chimerism: does it matter? (2004) (2)
- Results of a Prospective, Multicenter, Phase I/II Clinical Study in Pediatric and Adult Patients Using TCR Alpha/Beta and CD19 Depleted Haploidentical Hematopoietic Stem Cell Grafts Following Reduced-Intensity Conditioning (2018) (2)
- ADAPTER CHIMERIC ANTIGEN RECEPTOR EXPRESSING CELLS FOR TARGETING OF MULTIPLE ANTIGENS (2016) (2)
- Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism (2012) (2)
- Graft Manipulation (2018) (2)
- Immune recovery and immunotherapy after stem cell transplantation in children (2001) (2)
- iVacALL: utilizing next-generation sequencing for the establishment of an individual peptide vaccination approach for paediatric acute lymphoblastic leukaemia (2013) (2)
- Abstract B70: Universal adapter CAR-engineered NK-92 cells target patient-derived glioblastoma cancer stem cells (2020) (2)
- Determinants of antileukemia effects of allogeneic natural killer cells (2004) (2)
- Antiemetic prophylaxis with fosaprepitant and granisetron in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation (2020) (2)
- Haploidentical hematopoietic stem cell transplantation as individual treatment option in pediatric patients with very high-risk sarcomas (2023) (2)
- Identification and selective depletion of alloreactive T-cells for adoptive immunotherapy. (2010) (2)
- Reduced-Intensity Conditioning (RIC) in Haploidentical Transplantation. (2004) (1)
- The German PID-net registry (2017) (1)
- Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapy (2019) (1)
- Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors, (2011) (1)
- From Bedside To Bench: Molecular Benchmarking Of An Fc-Optimized CD19 Antibody Used In Treatment Of Relapsed and Refractory Pediatric B-Lineage Acute Lymphoblastic Leukemia (2013) (1)
- KTE-C19 (anti-CD19 chimeric antigen receptor [CAR] T cell therapy) in pediatric and adolescent patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL): Preliminary Results of ZUMA-4 (2017) (1)
- Adoptive Transfer of Hexon-Specific T-Cells as a Treatment of Adenovirus Reactivation Following Allogeneic Stem Cell Transplantation. (2009) (1)
- Preemptive administration of human alpha beta T cell receptor-targeting monoclonal antibody GZ-alpha beta TCR potently abrogates aggressive graft-versus-host disease in vivo (2015) (1)
- Supplementary Material for: Induction of Myeloid-Derived Suppressor Cells in Cryopyrin-Associated Periodic Syndromes (2016) (1)
- Immunological recovery following HLA‐matched CD3+ TCR αß+/CD19+ depleted hematopoietic stem cell transplantation in children (2022) (1)
- Case report 756: Chronic multifocal osteomyelitis. (1992) (1)
- A New Dosing Scheme of ATG-F Prevents Rejection and Maintains Immune Recovery in Haploidentical T and B Cell Depleted Stem Cell Transplantation (2012) (1)
- Childhood Leukemias: Hematopoietic stem cell transplantation (2006) (1)
- Chemotactic activity of substances derived from antibody-loaded tumor cells on granulocytes. (1994) (1)
- Protective T-cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections. (2021) (1)
- Abstract B144: Reduction of minimal residual disease in pediatric B-precursor acute lymphoblastic leukemia by an Fc-optimized CD19 antibody (2016) (1)
- Neoplastic Hematologic Disorders in Children and Adolescents (2018) (1)
- Antiemetic Prophylaxis with Fosaprepitant and 5-HT3-Receptor Antagonists in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation (2020) (1)
- Rapid method for purification of CD56+ natural killer cells with preferential enrichment of the CD56bright+ subset (1994) (1)
- Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia (2015) (1)
- Faster Engraftment and Immune Reconstitution after Haploidentical Allogenic Hematopoietic Cell Transplantation with CD3/CD19 Depleted as Compared to CD34 Selected Grafts. (2005) (1)
- Differential expression of THELPER1 cytokines upon antigen stimulation predicts ex vivo proliferative potential and cytokine production of virus‐specific T cells following re‐stimulation (2014) (1)
- Alternative Donor Stem Cell Transplantation In Aplastic Anemias and Refractory Cytopenias Is Save and Feasible With T- and B-Cell Depleted Haploidentical Grafts (2013) (1)
- Individualised Follow-Up for Patients after Haematopoietic Stem Cell Transplantation (HSCT) and Treatment for Relapse of Cancer (2012) (1)
- Rapid Immune Reconstitution after a Reduced-Intensity Conditioning Regimen and a CD3-Depleted Haploidentical Stem Cell Graft for Pediatric Refractory Hematologic Malignancies. (2006) (1)
- Correction to: Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature (2019) (1)
- Graft versus leukemia effects of natural killer cells in HLA mismatched hematopoietic transplantation (2003) (1)
- Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma—a pilot study (2022) (1)
- Abstract A131: Targeting B7-H3 (CD276) in neuroblastoma: In vitro evaluation of Fc-optimized antibodies and immunocytokines (2019) (1)
- Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma (2022) (1)
- Two-cavities approach for resection of pediatric abdominal neuroblastic tumors: experience of a national reference pediatric onco-surgical center (2022) (1)
- Effect of the HDAC inhibitor SAHA on the immunomodulatory properties of MSC and tumor stroma cells (2010) (1)
- Challenges in Gene Therapy for Somatic Reverted Mosaicism in X-Linked Combined Immunodeficiency by CRISPR/Cas9 and Prime Editing (2022) (1)
- Stem cell transplants for heavily transfused patients with severe aplastic anemia: a promising new strategy. (2004) (1)
- Hematopoietic stem cell transplantation with mesenchymal stromal cells in children with metachromatic leukodystrophy. (2022) (1)
- Haploidentical Transplants for Nonmalignant Diseases in Children (2018) (1)
- AML SCT-BFM 2007: Results of the Prospective Hematopoietic Stem Cell Transplantation (HCT) Trial of the Berlin-Frankfurt-Münster (BFM) Study Group for Children with Very High Risk Acute Myeloid Leukemia (2017) (1)
- 473: Rabbit ATG (thymoglobulin r) Pharmacokinetics in Pediatric Patients Receiving a Matched Unrelated Donor Bone Marrow Transplantation (2008) (1)
- Comparison Between Related T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation (TCD-Haplo) and Umbilical Cord Blood Transplantation (UCBT) in Pediatric Patients with Acute Leukemia, a Eurocord, PDWP-EBMT Study (2014) (1)
- Could (should) we abandon total body irradiation for conditioning in children with leukemia. (2022) (1)
- Consultations in Molecular Diagnostics Dynamics of the Emergence of a Human Cytomegalovirus UL97 Mutant Strain Conferring Ganciclovir Resistance in a Pediatric Stem-Cell Transplant Recipient (2009) (1)
- Introducing isotonic fluids into pediatric oncology (2021) (1)
- Differential Diagnosis of Infantile Osteomyelitis - Classification according to Scintigraphic, Radiologie and Magnetic Resonance Tomographic Findings (1996) (1)
- The role of interferon-gamma in the immunotherapy of neuroblastoma. (1991) (1)
- Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates. (2021) (1)
- A Prospective, Multicenter Study of Closed System Extracorporeal Photopheresis for Children With Steroid-Refractory Acute Graft-Versus-Host Disease. (2022) (1)
- 110 SOMATOMEDINS POTENTIATE INTERLEUKIN 2 INDUCED STIMULATION OF NATURAL KILLER CELL ACTIVITY (1988) (1)
- Safety and Feasibility of Posaconazole as Oral Antifungal Prophylaxis In Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation. (2010) (1)
- Leukemia Related Co-Stimulation / Co-Inhibition Predict T-Cell Attack of Acute Lymphoblastic Leukemia Mediated By Blinatumomab (2015) (1)
- Human Leukocyte Antigen Distribution in German Caucasians with Advanced Ewing’s Sarcoma (2012) (1)
- [Functional significance of CD56 large granular lymphocytes in the decidua in early pregnancy in the human]. (1995) (1)
- Rabbit anti-thymocyte globulin (rATG;thymoglobulin®) pharmacokinetics in pediatric patients receiving a hematopoietic stem cell transplant (HSCT) (2006) (1)
- [Indications for autologous bone marrow transplantation in pediatric oncology. Results of the 5th meeting of experts of the Kind-Philipp Foundation, Riesensburg, November 1988]. (1989) (1)
- Author Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2021) (1)
- Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial. (2023) (1)
- IL-2 Treatment in a Patient with Stage IV Neuroblastoma After Allogeneic Bone Marrow Transplantation (1990) (1)
- Successful autologous stem cell transplantation (ASCT) in a patient with juvenile dermatomyositis (2008) (1)
- Do children, adolescents, and young adults with soft tissue sarcoma benefit from early detection of recurrences? Results of a population-based study. (2012) (1)
- Retrospective Analysis of Itraconacole, Voriconazole and Posaconazole As Oral Antifungal Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation (2011) (1)
- Role of Monocytes and Pro-Inflammatory Th17 Cells Expressing Multi-Drug Resistance Protein Type 1 in the Pathogenesis of Graft-Versus-Host Disease (2015) (1)
- RNA ImmunoGenic Assay: A Method to Detect Immunogenicity of in vitro Transcribed mRNA in Human Whole Blood. (2020) (1)
- Low leukemia burden improves blinatumomab efficacy in patients with relapsed/refractory B‐cell acute lymphoblastic leukemia (2023) (1)
- Final results of a multicenter phase I/II study using CD3/CD19 depleted stem cells for haploidentical transplantation in children (2016) (0)
- KIR Haplotype B Donors but Not KIR-Ligand Mismatch Result in a Reduced Risk of Relapse After Haploidentical Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning and a CD3/CD19 Depleted Graft. (2012) (0)
- Validation of Automatic Greulich-Pyle Bone Age on Children with short stature of various diagnoses (2011) (0)
- Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants (2016) (0)
- Characterisation of sialylation patterns on the surface of physiologic immune effector cells and tumour cells (2009) (0)
- Allogeneic Stem Cell Transplantation (2018) (0)
- Targeting Calcineurin Inhibitor-Induced Arterial Hypertension in Liver Transplanted Children Using Hydrochlorothiazide. (2022) (0)
- Abstract A113: iVacALL: A personalized peptide-vaccination design platform for pediatric acute lymphoblastic leukemia patients based on patient-individual tumor-specific variants (2016) (0)
- Suicidal T cells: a jump-start for the thymus. (2012) (0)
- The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation: Organizing Committee (2019) (0)
- Abstract A140: A T-cell utilizing bispecific anti-CD3/GD2 construct mediates superior in vitro efficacy compared to CH14.18 mAb in neuroblastoma patients after allogeneic SCT (2019) (0)
- Transient but Reversible Activation Defect of T-Cell Responses Against Cytomegalovirus and Adenovirus through Immunosuppresion with Calcineurin Inhibitors. (2010) (0)
- Hematopoietic Stem Cell Therapy In Eight Patients with Metachromatic Leukodystrophy – Relevance of Post-Transplant Medication. (2010) (0)
- The Importance of Harmonizing Transplantation Procedures in Children with ALL: ALL-SCT-BFM 2003, a Prospective Multicenter Trial. (2007) (0)
- Retransplantation From Haploidentical Donors After Graft Failure in Pediatric Patients Results in Low Transplant Related Mortality and Favourable Long Term Survival (2011) (0)
- EVI-1 Mediates Apoptosis Resistance Via CD261 Induction and Enhances Leukemogenic Potential in Human Acute Lymphoblastic Leukemia (2011) (0)
- Long Term Survival And Relapse Rate After Transplantation Of Highly T And B Cell Depleted Stem Cells From Alternative Donors In Pediatric Patients With Acute Lymphatic Leukemia (2010) (0)
- Special aspects of stem cell therapy in patients with MLD (2010) (0)
- Establishment and Characterization of a Cell Line ( Wa-2 ) Derived from an Extrarenai Rhabdoid Tumor 1 (2006) (0)
- Paediatric diseases (2001) (0)
- Inadvertent intravenous administration of maternal breast milk in a six-week-old infant: a case report and review of the literature (2014) (0)
- Vaccine Virus-Based Oncolysis Susceptibility of Sarcoma Cells to Measles Innate Immune Defense Defines (2014) (0)
- Automated production of specific T cells for treatment of refractory viral infections after allogeneic stem cell transplantation. (2023) (0)
- The role of γδ T cells in the context of allogeneic stem cell transplantation (2022) (0)
- Innate immune defence defines susceptibility of gastrointestinal and non-gastrointestinal sarcomas to measles vaccine virus based virotherapy (2012) (0)
- Myeloperoxidase-Positive and Negative Granulocytes: Investigations by Flow Cytometry (2000) (0)
- Siglec-7 Tetramers Characterize B Cell Subpopulations and Identify Immunomodulatory Ligands on Malignant Cells (2010) (0)
- GvHD and Engraftment after Haploidentical Stem Cell Transplantation. A Comparison of 3 Immunomagnetic Selection Procedures. (2004) (0)
- Pediatric Patients Transplanted with Positive Selected Stem Cells from Alternative Donors Have a Low Incidence of CMV Dnaemia. (2004) (0)
- Impressum, Vol. 21, supplement 3, 1994 (1994) (0)
- Allogeneic HSCT from Unrelated and Sibling Donors are Equal for Children with Acute Lymphoblastic Leukemia (2013) (0)
- Secretion of Angiogenic Proteins by Human Multipotent Mesenchymal Stromal Cells (MSC) under Hypoxic Culture Conditions and Clinical Application of MSC in Steroid Induced Osteonecrosis in Children. (2007) (0)
- Transplantation of Positive Selected Peripheral Stem Cells with Add-Back of T Cells from Unrelated Donors in Children: Favourable Survival and Low Incidence of GvHD. (2006) (0)
- depleted allografts - blasts with effector cells from pediatric patients who received T-cell Chimeric CD19 antibody mediates cytotoxic activity against leukemic (2013) (0)
- Chemically modified mRNA as a novel treatment for cystic fibrosis (2013) (0)
- [Autologous bone marrow transplantation]. (1994) (0)
- Selective Allo-depletion: TcRαβ and CD19+ T-Cell Depletion (2018) (0)
- Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis (2018) (0)
- Successful Adoptive Immunotransfers in a Boy with Relapse of T-ALL After Bone Marrow Transplantation from an Unrelated Donor (1994) (0)
- Allogeneic Stem-Cell Transplantation in Children and Adolescents with Malignancies (2020) (0)
- Targeted Deep Sequencing of Genetic Alterations Identified By Whole Exome Sequencing Reveals Clonal Evolution in Pediatric T-Lymphoblastic Leukemia (2014) (0)
- D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma (2022) (0)
- Megadose transplantation of haploidentical stem cells in children (2003) (0)
- Insulin-like growth factors I and II potentiate the stimulatory effect of interleukin 2 on natural killer cell activity (1988) (0)
- IL-12- and IL-2-induced release of IFN-gamma by CD56++ uterine large granular lymphocytes (LGLs) is amplified by decidual macrophages (1996) (0)
- Human Multipotent Mesenchymal Stromal Cells Inhibit Proliferation of PBMC in the Absence of Functional IFNγR1 and IDO Expression. (2006) (0)
- Alloreactivity of Natural Killer Cell Clones Against Childhood Precursor-B Lymphoblastic Leukemia Cells Is Determined by Differential KIR Expression. (2006) (0)
- The Receptor Tyrosine Kinase ~ 1 8 5 ~ ~ ~ ~ Is Expressed on a Subset of B-Lymphoid Blasts Prom Patients With Acute Lymphoblastic Leukemia and Chronic Myelogenous Leukemia (2002) (0)
- Inhalt – Contents, Vol. 21, supplement 3, 1994 (1994) (0)
- Interferon-Gamma Up-Regulates the Susceptibility of Human Neuroblastoma Cells to Natural Killer Cell-Mediated and Antibody-Dependent Cellular Cytotoxicity1 (1990) (0)
- Use of IL15 Stimulated, CD3/19 Depleted Transplants From Haploidentical Donors In Pediatric Malignancies (2010) (0)
- emolytic Uremic Syndrome after Bone Marrow ransplantation : Clinical Characteristics and Outcome n Children (2005) (0)
- Abstract A080: Cytokine-induced senescence in neuroblastoma cell lines: Therapeutic option or idle wish? (2019) (0)
- Strategies for the small scale enrichment of cord blood hematopoietic CD34+ cells (1998) (0)
- Significant Reduction of Treatment Related Mortality after Stem Cell Transplantation in 647 Children and Adolescents with ALL within BFM Trials during the Last 12 Years: A Long Term Analysis from 1996 to 2007 (2008) (0)
- Ralph A. Reisfeld, PhD: In Memoriam (1926–2020) (2021) (0)
- Abstract 658: Translational theranostic imaging of lymphoma using radiolabeled αCD19-antibodies (2018) (0)
- Combined use of 4-color flow cytometry and real-time PCR to detect minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (2004) (0)
- Detection of Th1 Driven T-Cell Responses in Peripheral Could Guide Individualized Immunosuppression and Risk of Viral Reactivation Under GvHD Prophylaxis Following Allogeneic Stem Cell Transplantation. (2012) (0)
- Ex Vivo Expansion and Activation of Natural Killer Cells from Thalassemia Patients for Adoptive Immunotherapy of Tumors (2022) (0)
- Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003 (2010) (0)
- Haploidentical Stem Cell Transplantation for Children with High-Risk Leukemia In Chile: Report of the First 15 Cases. (2010) (0)
- In Vivo Developing Immunotherapy of Ex Vivo Expansion of Human Natural Killer Cells from Thalassemia Patients for Leukaemia (2022) (0)
- Hoechst 33342 Staining Identifies the Progenitor Side Population in NOD.Cg-PrkdcscidIL2rgtmWjl/Sz Mice Harboring Pediatric Leukemias. (2015) (0)
- A process for Tumorzelldepletion CD34-positive cells (1996) (0)
- Serving his patients with passion and dedication—Obituary to Prof. Dr. Dr. h.c. Dietrich Niethammer (2020) (0)
- CRISPR medicine for blood disorders: Progress and challenges in delivery (2023) (0)
- Eradication of Pulmonary Aspergillosis in an Adolescent Patient Undergoing Three Allogeneic Stem Cell Transplantations for Acute Lymphoblastic Leukemia (2012) (0)
- Induction of interleukin-10 during extracorporeal circulation (1999) (0)
- CRISPR Medicine: Advance, Progress and Challenges (2021) (0)
- First-in-Humans PET/MRI of In Vivo GD2 Expression in Osteosarcoma (2022) (0)
- Immunological long-term follow-up of neuroblastoma stage IV patients after anti-GD2 CH14.18 antibody treatment. (2015) (0)
- Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation (2022) (0)
- Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies. (2023) (0)
- NK Cell Activity Influences Long Term Outcome of Pediatric Leucemias After T Cell Depleted Stem Cell Transplantation (2011) (0)
- NY-ESO-1 specific CD4+ Thelper1 cells for immunotherapy of cancer. (2014) (0)
- Better Outcome With Maintenance Therapy : Pediatric Patients With Stage Iv Soft Tissue Sarcoma Benefit From Long Term Therapy Compared To Sct Or No Further Therapy (2015) (0)
- Procalcitonin and C-Reactive Protein during Transplant-Related Adverse Events after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients (2018) (0)
- Pharmacokinetic Analysis during Antifungal Prophylaxis with Posaconazole Suspension in Pediatric and Adolescent Patients after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (0)
- Glucose Metabolism and the Antioxidative Defense System in Cancer Cells: Options for the Application of ROS-based Anticancer Drugs (2014) (0)
- Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults with CD3/CD19-Depleted Grafts after Reduced-Intensity Conditioning: A Phase I/II Study. (2007) (0)
- Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation. (2022) (0)
- A Phase I/II Study Of Cyclophosphamide and Topotecan In Patients With High-Risk Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation: The St. Jude Long-Term Follow-Up (2009) (0)
- Detection of biomarkers in blood macrophages via EDIM blood test in nephroblastoma patients (2016) (0)
- Transplantation of Megadoses of Highly Purified Haploidentical Stem Cells: Overcoming The HLA Barrier (1999) (0)
- Haploidentical TCRab Depleted Hematopoietic Cell Transplantation Leads To Rapid Immune Reconstitution and Promising Clinical Outcome In Adults (2013) (0)
- Detection of minimal neuroblastoma cell contamination using tyrosine hydroxylase nested RT-PCR depends on basal tyrosine hydroxylase gene expression (2007) (0)
- Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia (TDT) or Sickle Cell Disease (SCD): Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-Cas9-Modified CD34+ Hematopoietic Stem and Progenitor Cells (HSPCs) (2021) (0)
- Contents, Vol. 33, 1992 (1992) (0)
- Free Papers (2014) (0)
- Generation of specific polyclonal and polyfunctional CD4+ T-helper1 cells against WT-1, MAGE-A3, Survivin and ROR-1 for adoptive T-cell immunotherapy. (2015) (0)
- The DC activation marker CD83 binds to a CD4+ subpopulation of PBMC - options for immune therapy (2004) (0)
- Cidofovir Is Safe and Effective in the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplantation. (2004) (0)
- Immune Reconstitution after Haploidentical Stem Cell Transplantation (2003) (0)
- High Dose Defibrotide as Therapy for Pediatric Patients with Veno-Occlusive Disease of the Liver. (2006) (0)
- Cytokine serum levels during post-transplant adverse events in 61 pediatric patients after hematopoietic stem cell transplantation (2015) (0)
- Haploidentical Allogeneic Hematopoietic Cell Transplantation in Adults with Reduced-Intensity Conditioning and CD3/CD19-Depleted Grafts: Low Toxicity and Fast Engraftment. (2006) (0)
- Human multipotent mesenchymal stromal cells express different members of the galectin family with immunomodulatory functions (2009) (0)
- Human Peripheral CD34+ γδ T Cells Can Transdifferentiate into αβ T Cells. (2012) (0)
- Adoptive Transfer of Adenovirus Specific T-Cells in Children with Systemic Adenovirus Infection after Allogeneic Stem Cell Transplantation. (2005) (0)
- Alternative donor HSCT in refractory acquired aplastic anemia: The time has come (2012) (0)
- Arsenic Trioxide Inhibits Growth of Rhabdoid Cell Line KD (2014) (0)
- Armed oncolytic measles vaccine virus – a novel therapeutic agent for virotherapy of solid tumors (2011) (0)
- A Multidimensional Approach to Measuring Distress in Children Undergoing Hematopoietic Stem Cell Transplantation: Three Raters’ Perspectives and Stress Biomarkers in Saliva and Blood (2022) (0)
- Abstract 5354: Characterisation of the cell line HC-AFW1 derived from a paediatric hepatocellular carcinoma (2011) (0)
- Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine. (1991) (0)
- Quantitative HLA Class I Expression and KIR-Mismatch between NK-Cell-Donor and Patient Predict NK Cell Mediated Lysis of Leukemic Cells from Children with Acute Lymphatic Leukemia. (2006) (0)
- Armed oncolytic measles vaccine virus–a novel therapeutic agent for virotherapy of sarcomas of gastrointestinal and non-gastrointestinal origin (2012) (0)
- Beyond the FACS (2007) (0)
- The role of graft-versus-host disease in the inhibition of normal B-lymphopoiesis and leukemic control of B-lineage acute lymphocytic leukemia after allogeneic stem cell transplantation. (2006) (0)
- Isolation and Ex Vivo Culture of Vδ1+CD4+γδ T Cells, an Extrathymic αβT-cell Progenitor. (2015) (0)
- Paediatric diseases (2001) (0)
- infant acute lymphoblastic leukemia KIR-incompatible hematopoietic-cell transplantation for poor prognosis (2013) (0)
- Tumor stromal cells from pediatric tumors impair NK cell function and alter NKp receptor expression (2009) (0)
- Correction: mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo (2018) (0)
- High Progenitor Cell Frequency at Diagnosis Predicts High Minimal residual Disease Level in Childhood ALL. (2009) (0)
- Sa.120. Receptor-Mediated Endocytosis of Hsp70-Chaperoned (Auto-) Antigenic Peptides Enhances the Activation of (Auto-) Antigen-Specific CD4+ T-Cells in Healthy Donors (2006) (0)
- Characterization of human MSC propagated in animal serum-free cultures and clinical application of MSC in paediatric patients. (2006) (0)
- A Phase I/II Study of Cyclophosphamide and Topotecan in Patients with High-Risk Malignancies Undergoing Autologous Hematopoietic Cell Transplantation: The St. Jude Long-term Follow-up (2016) (0)
- Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance (1991) (0)
- Correction: Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study (2021) (0)
- Improved T Cell Recovery After Transplantation of CD3/CD19 depleted Haploidentical Stem Cell Grafts in Pediatric Patients. (2009) (0)
- Reply: Missing ligand model in autologous stem cell transplantation (2007) (0)
- Which patients with rhabdomyosarcoma (RMS) do need radiotherapy (RTX)? The long-term results of the CWS studies -81, -86, -91, and -96. (2014) (0)
- Bone Marrow Transplantation from an Unrelated Donor: Experiences in Children (1994) (0)
- LYMPHOID NEOPLASIA Both mature KIR 1 and immature KIR 2 NK cells control pediatric acute B-cell precursor leukemia in NOD.Cg-Prkdc scid IL2rg tmWjl /Sz mice (2014) (0)
- Transferring measurable residual disease measurement in pediatric acute lymphoblastic leukemia from quantitative real-time PCR to digital droplet PCR. (2023) (0)
- Infection Control and Management of COVID-19: Challenges for Paediatric Tertiary Care Hospitals (2020) (0)
- Abstract IA09: Immunotherapeutic approaches for pediatric solid tumors (2020) (0)
- 62: High Resolution HLA Typing and ATG Prevent Children with all from GVHD and Treatment Related Mortality After Unrelated Donor Stem Cell Transplantation (2008) (0)
- Preliminary Experience with Haploidentical Stem Cell Transplantation for Children with Sickle Cell Disease and Stroke. (2005) (0)
- Improved T Cell Recovery After Transplantation Of CD3/CD19 Depleted Haploidentical Stem Cell Grafts In Pediatric Patients (2010) (0)
- Whole Exome Sequencing In Relapsed Pediatric T-ALL: Progression Into Relapse Is Characterized By An Increased Number Of Somatic Mutations and a Conservation Of Mutations In Leukemogenic Driver Genes (2013) (0)
- Methemoglobin Formation in Erythrocytes Stored for Different Time Periods during Extracorporeal Circulation (2017) (0)
- Transfer of Ex Vivo Expanded NK and γδT Cells from Untouched Posttransplant PBMCs to Clear Minimal Residual Disease in Acute Myeloid Leukemia (2014) (0)
- 6001 ORAL Immunosuppressive TLI-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoeitic stem cell transplantation (2007) (0)
- Dominant T-Cell Clonal Expansion Associated with Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients. (2004) (0)
- Isolation and Ex Vivo Culture of V delta 1(+) CD4(+) gamma delta T Cells, an Extrathymic alpha beta T-cell Progenitor (2015) (0)
- Human &ggr;&dgr; T Lymphocytes Exert Natural and IL-2–Induced Cytotoxicity to Neuroblastoma Cells (2000) (0)
- 207Allogeneic bone marrow transplantation for children with hematologic malignancies (2003) (0)
- Haploidentical transplants Effective donor lymphohematopoietic reconstitution after haploidentical CD34 þ -selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia (2004) (0)
- Long Term Survival and Relapse Rate After Transplantation of Highly T and B Cell Depleted Stem Cells From Alternative Donors in Pediatric Patients with Acute Lymphatic Leukemia. (2009) (0)
- Haploidentical allogeneic haematopoietic cell transplantation with Cd34 selected stem cells for the treatment of haematologic malignancies: high survival and low incidence of Gvhd (2004) (0)
- Surface HLA-DR Expression in Monocyte Subpopulations During Adverse Events After Hematopoietic Stem Cell Transplantation (2011) (0)
- Boosts with Highly Purified Stem Cells Can Improve Hematopoietic Regeneration after Allogeneic Transplantation from Alternative Donors. (2005) (0)
- Contents, Vol. 35, Supplement 1, 1995 (1995) (0)
- Expression of Activating Natural Killer Cell Receptor Ligands in Childhood Acute Lymphoblastic Leukemia. (2006) (0)
- Megadose and minitransplantation: what is the biology? (2000) (0)
- Correction: Hematopoietic stem cell transplantation for children with acute myeloid leukemia—results of the AML SCT-BFM 2007 trial (2019) (0)
- Pediatric T-ALL but Not cALL Blasts Express Ligands for Siglec-7 Inhibiting NK Cell Mediated Lysis. (2006) (0)
- Characteristic glycosylation patterns of human immune cells in NOD/SCID IL2Rγnull mice (2010) (0)
- Abstract 4196: Successful establishment of human rhabdomyosarcoma xenografts in a human-adapted mouse model (2010) (0)
- OR.29. Role of Scavenger Receptors as Endocytotic Receptors for Human Hsp70 in MHC Class II-dependent Antigen Presentation (2008) (0)
- Flow Cytometry Based Chimerism Analysis Can Predict Graft Rejection in Pediatric Patients Receiving HLA Mismatched Stem Cell Transplantation (2012) (0)
- The interferon induced 2-5A system in neuroblastoma. (1991) (0)
- Hematopoietic Progenitor Cell Transplantation from Parental Donors for Children with Sickle Cell Anemia and Stroke. (2007) (0)
- [Technical aspects of autologous bone marrow transplantation]. (1994) (0)
- Allogeneic NK Cells Determinants of Antileukemia Effects of (2003) (0)
- Immunosuppressive TLI-Based Reconditioning Regimens Enable Engraftment After Graft Rejection or Graft Failure in Patients Treated With Allogeneic Hematopoeitic Stem Cell Transplantation (2007) (0)
- Acute graft-versus-host disease and immunosuppressive therapy identify patients less likely to have a diagnostic yield with a bronchoalveolar lavage: The St. Jude experience 1990–2002 (2006) (0)
- Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud (2015) (0)
- The Potential Role of Natural Killer Cells in the Treatment of Malignant Disease (2008) (0)
- Antiemetic Prophylaxis with Granisetron and Fosaprepitant during Moderate and High Emetogenic Chemotherapy in Pediatric Patients (2017) (0)
- donors in pediatric leukemia Transplantation of highly purified CD34+ progenitor cells from unrelated (2013) (0)
- 203Allogeneic bone marrow transplantation for children with myeloid hematologic malignancies (2003) (0)
- Antitumor activity of Zerumbone in rhabdomyosarcoma (2016) (0)
- Invariant Natural Killer T Cells from Donor Lymphocyte Infusions (DLI-iNKTs) Contribute to Anti-Tumor Immunity after Allogeneic Hematopoietic Cell Transplantation (2018) (0)
- Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma (2022) (0)
- Use of a Fc-Optimized CD19 Antibody for Treatment of MRD in Pediatric Patients with B-Lineage Acute Lymphoblastic Leukemia (2012) (0)
- Future Prospects: Haploidentical Transplantation (2018) (0)
- Transplantation of Haploidentical CD3/CD19 Depleted Stem Cells in Children: Final Results of a Multicenter Phase I/II Study (2016) (0)
- Synergistic Effect Of Nifurtimox and Inhibition Of Hsp70/Hsp90 In Treatment Of Neuroblastoma (2013) (0)
- Paediatric diseases (2000) (0)
- CHAPTER 29 – Transplants from unrelated or mismatched family donors (2009) (0)
- DDDT_A_214264 3439..3451 (2019) (0)
- Fibrosis Lung Disease Infection in Cystic Pseudomonas aeruginosa Suppressor Cells: Implications for Flagellin Induces Myeloid-Derived (2013) (0)
- Human peripheral Vδ1+ γδ T cells can develop into αβ T cells (P4460) (2013) (0)
- DDDT_A_260887 3915..3927 (2020) (0)
- Involvement Of S100 Proteins and Hsp90 In The Pathogenesis Of Graft-Versus-Host Disease After Allogeneic Hematopoetic Cell Transplantation (2013) (0)
- Specific sialylation patterns of neuroblastoma – mechanism of immune evasion? (2009) (0)
- Allogeneic Blood Stem Cell Donors Genotyping and Phenotyping for Selection of Comparison of Killer Ig-Like Receptor (2005) (0)
- Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (2018) (0)
- Prophylaxis of Chemotherapy-Induced Nausea and Vomiting with Fosaprepitant and Granisetron in Pediatric Patients after Allogeneic HSCT (2018) (0)
- Interleukin-12- and interleukin-2-stimulated release of interferon- γ by uterine CD56 (cid:70)(cid:70) large granular lymphocytes is amplified by decidual macrophages (1997) (0)
- Co-Transfusion of Donor NK Cells in Haploidentical Stem Cell Transplantation (2008) (0)
- Patterns of HLA-DR Surface Expression on CD14+ Monocytes During Adverse Events After Hematopoietic Stem Cell Transplantation. (2010) (0)
- Treatment of Adenovirus Infection After Haploidentical Stem Cell Transplantation in Children (2010) (0)
- Transplantation for Congenital Sideroblastic Anaemia Is Feasible and Offers Outcomes Comparable to Other Transfusion Dependent Anaemias. a Joint Retrospective Study of the Paediatric Diseases and Severe Aplastic Anaemia Working Parties (PDWP/SAAWP) of EBMT (2020) (0)
- OC-0248: Immunotherapy with NHS-IL12 in combination with local irradiation to achieve tumour control (2014) (0)
- A treosulfan-based toxicity-reduced conditioning regimen is safe and feasible for children with non-malignant diseases but increases rejection rates in stem cell transplantation of hemoglobinopathies (2016) (0)
- Melphalan and cytarabine as a salvage therapy in children with relapsed or refractory acute leukemia (2020) (0)
- CD3/CD19 Depleted Grafts for Haploidentical Stem Cell Transplantation in Children: Results of a Pilot Study. (2006) (0)
- Use of Ex Vivo Graft Manipulation and Posttransplant Cyclophosphamide Result in Low GvHD Rates and Acceptable Engraftment after RIC Regimens in Pediatric Mismatched SCT (2019) (0)
- Decentralized Manufacture of TCR-Alpha/Beta and CD19 Depleted Haploidentical Stem Cell Grafts for Children within a Multicenter Phase I/II Clinical Trial (2016) (0)
- Evaluation Of Alloimmune Responses In Humanized NOD/SCID/IL2rgnull Mice Following Human CD34+ Stem Cell Transplantation (2009) (0)
- Ex vivo and in vivo T-cell depletion in allogeneic transplantation: towards less or non-cytotoxic conditioning regimens (2022) (0)
- Editorial to: Advance in the Treatment of Pediatric Leukemia (2022) (0)
- 297: Establishment of a chimeric NOD-scid/IL2RγcNull transplantation-model to evaluate graft-vs-host and graft-vs-leukemia immune responses of ex vivo modified human T lymphocyte grafts (2007) (0)
- Clinical Grade Generation of T-Helper-1-Driven Polyclonal T-Cell Populations for Adoptive Immunotherapy Against Tumor Associated Antigens (2011) (0)
- Hexon Specific T-Cells for Adoptive T-Cell Transfer as a Treatment of Adenovirus Infection after Allogeneic Stem Cell Transplantation. (2006) (0)
- A review of the use of topotecan for mobilization of peripheral blood stem cells in autologous hematopoietic stem cell transplantation (2006) (0)
- Antifungal prophylaxis with posaconazole suspension versus tablet in pediatric patients after hematopoietic stem cell transplantation (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Rupert J. Handgretinger?
Rupert J. Handgretinger is affiliated with the following schools:
